evidence specific effect serum patient cystic fibrosis sodiumdependent glucose transport rat jejunum serum patient cystic fibrosis pancreas cf normal human serum assayed ability inhibit sodium dependent glucose transport rat brushborder membrane vesicle fresh cf age sexmatched control serum inhibitory compared physiologic saline inhibition cf serum 44 13 mean sd final serum concentration 67 67 34 10 serum 68 28 20 serum ratio inhibition cf serum compared control serum 100 078 093 67 10 20 serum concentration respectively although slightly greater inhibition cf serum observed concentration 10 probably significant difference could detected concentration 20 serum glucose transport presence serum sensitive phlorizin indicating residual glucose transport proceeding sodiumdependent glucose transport system finding suggest cf serum specifically inhibit sodiumdependent glucose transport system intravesicular space accessible glucose reduced presence cf control serum fresh cf serum 14 time effective fresh control serum p le 001 presence substantial vesicle shrinking activity control serum indicates activity cannot considered specific cf